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Background: Pregnant women have an increased risk of influenza complications. Influenza vaccination during
pregnancy is safe and effective, however coverage in Australia is less than 40%. Pregnant women who receive a
recommendation for influenza vaccination from a health care provider are more likely to receive it, however the
perspectives of Australian general practitioners has not previously been reported. The aim of the study was to
investigate the knowledge, attitudes, beliefs, and practices of general practitioners practicing in South-Western
Sydney, Australia towards influenza vaccination during pregnancy.
Methods: A qualitative descriptive study was conducted, with semi-structured interviews completed with
seventeen general practitioners in October 2012. A thematic analysis was undertaken by four researchers, and
transcripts were analysed using N-Vivo software according to agreed codes.
Results: One-third of the general practitioners interviewed did not consider influenza during pregnancy to be a
serious risk for the mother or the baby. The majority of the general practitioners were aware of the government
recommendations for influenza vaccination during pregnancy, but few general practitioners were confident of their
knowledge about the vaccine and most felt they needed more information. More than half the general
practitioners had significant concerns about the safety of influenza vaccination during pregnancy. Their practices in
the provision of the vaccine were related to their perception of risk of influenza during pregnancy and their
confidence about the safety of the vaccine. While two-thirds reported that they are recommending influenza
vaccination to their pregnant patients, many were adopting principles of patient-informed choice in their approach
and encouraged women to decide for themselves whether they would receive the vaccine.
Conclusions: General practitioners have varied knowledge, attitudes, and beliefs about influenza vaccination during
pregnancy, which influence their practices. Addressing these could have a significant impact on improving vaccine
uptake during pregnancy.
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Pre-natal influenza infection is associated with an in-
creased risk for both mother and baby, including re-
spiratory and cardio-pulmonary hospitalisation, pre-term
delivery, fetal distress, and in some cases death [1-7].
These risks are compounded when the mother has co-
morbidities such as asthma or diabetes, or is infected
with a pandemic strain of the virus [4,8]. The most ef-
fective strategy for preventing influenza in pregnant
women is immunisation, and benefits for both the
mother and the infant have been demonstrated, with
maternal immunisation significantly reducing respiratory
illnesses in both the women and their infants in the first
six months of life [9-11]. Influenza vaccination during
any trimester of pregnancy is considered safe for both
the mother and the foetus [12-15]. It is recommended
that all pregnant women in Australia receive the vaccine,
[16-18] and these guidelines have been in place for more
than six years. The vaccine is available free of charge to
pregnant women in Australia. However, the proportion
of pregnant women who receive the vaccine is low, with
coverage between 10 and 40% [19-23].
While many factors may influence influenza vaccine up-
take during pregnancy, it has been identified that pregnant
women who receive a recommendation for the vaccine
from a health care provider are more likely to receive the
vaccine [22,24-27]. However, antenatal care providers do
not routinely recommend influenza vaccination to their
pregnant patients: three recent surveys of pregnant and
post-partum women in Australia found that only 21–41%
of women could recall receiving such a recommendation
[21-23]. Where a recommendation was given, approxi-
mately half were by a general practitioner [22,23].
Antenatal care providers are more likely to recommend
the influenza vaccine to pregnant women if they have
good knowledge about influenza and influenza vaccination
during pregnancy, positive attitudes towards influenza
vaccination during pregnancy, have observed serious med-
ical conditions due to influenza, or have personally re-
ceived the influenza vaccine [22,28-30]. These studies,
which investigated the knowledge, attitudes, and practices
of antenatal care providers towards influenza vaccination
during pregnancy, have mainly relied on data gathered
using written survey techniques in antenatal care settings
such as a hospital or clinic. No studies have been under-
taken in the Australian primary health care context, and
little is known about the perceptions of general practi-
tioners who are the main provider group or avenue
through whom pregnant women can access influenza vac-
cination. The attitudes and practices of general practi-
tioners are therefore likely to have a significant influence
on influenza vaccine uptake during pregnancy.
In early 2012, strategies to improve awareness about
influenza vaccination during pregnancy among generalpractitioners working in central and south-western
Sydney were implemented. The local director of public
health with the directors of obstetrics wrote to all gen-
eral practitioners in the region reminding them of the
recommendation to vaccinate pregnant women for influ-
enza, and referring them to a recent evidence-based
statement [18]. They were also provided with multiple
copies of a brochure designed to encourage women to
be vaccinated, [31] and a reminder stamp about the vac-
cine was placed in patient-held antenatal care cards.
The aim of this study therefore was to investigate the
knowledge, attitudes, beliefs, and practices of general
practitioners in the Sydney and South-Western Sydney
Local Health Districts in Australia towards influenza
vaccination during pregnancy, using qualitative method-
ology. The qualitative approach was used to provide rich
information on the perspectives of the general practi-
tioners, to identify their practices regarding influenza
vaccination during pregnancy, and their knowledge, atti-
tudes, and beliefs that inform these practices.
Methods
A qualitative descriptive methodology [32] was used to
describe general practitioners knowledge, attitudes, be-
liefs, and practices regarding influenza vaccination dur-
ing pregnancy, and to generate knowledge that can be
applied to practice.
Purposive sampling [33] was used to select general
practitioners to ensure diversity in terms of the location
of the general practice, the practice size, and the practi-
tioner’s sex. A matrix was developed to map these char-
acteristics to guide participant selection informed by a
detailed list of all 666 general practices in the Sydney
and South-Western Sydney Local Health Districts. The
matrix fields included size of the practice (a large prac-
tice is where there are 3 or more general practitioners),
type of local government area (urban and rural) and sex
of general practitioners within a practice. From this
matrix, 44 general practitioners were selected to be in-
vited to participate in the study, to ensure that sex,
practice size and type of local government area were
evenly represented. It was estimated that twenty partici-
pants would be required to reach saturation, therefore
with an estimated participation rate of less than 50%,
forty-four general practitioners were selected to be
invited. A low participation rate was expected, due to
the high workload and competing demands faced by
general practitioners which may limit their availability
to participate.
The 44 selected general practitioners were initially con-
tacted by letter, and subsequently by telephone, to invite
them to participate. A semi-structured interview guide, using
open-ended questions, was developed and consisted of the
following broad topic sections: reflections on antenatal care
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attitudes and practices about influenza vaccination during
pregnancy, perceptions of women’s attitudes towards in-
fluenza vaccination during pregnancy, and reflections on
how to improve and record coverage rates of influenza
vaccination during pregnancy. Within each section of the
interview topic guide, more detailed questions and specific
probes were prepared to allow the discussion to develop.
The interview questions were piloted with two non-
participating general practitioners and minor modifica-
tions were made to question expression. Semi-structured
interviews were conducted in person with all consenting
general practitioners in their place of practice by the one
researcher (LM) in September 2012. The duration of each
interview ranged from fifteen to forty-five minutes. Inter-
views were audio-recorded and transcribed verbatim by
an independent transcriber.
Four researchers (LM, KW, AD, KH) conducted the
analysis. Transcripts were read and re-read by the four
researchers several times who then met to discuss the
emergent concepts, themes and issues across the dataset.
Consensus was reached on the main themes and cat-
egories to be included in the analysis, based on the aim
of the study, and a conceptual framework was developed
to capture this. The researchers undertook a closer ana-
lysis of each transcript using the conceptual framework
to direct this. The qualitative research software tool
N-Vivo was employed to code the transcripts using a
constant comparative method [34] and each researcher
generated a diagrammatic model to illustrate their cod-
ing and patterns. These models were then synthesised
and guided the reporting process.
This project was approved by the Sydney Local Health
District Human Research Ethics Committee (RPAH Zone).
Results
Of the 44 general practitioners selected, 17 agreed to
participate in the study: nine females and eight males;
ten from small and seven from large practices; and six
from Sydney Local Health District and eleven from South
Western Sydney Local Health District. The reasons for
non-participation were not ascertained.
Thirty main codes were identified, and grouped into
three main categories: (1) general practitioners’ risk per-
ception of influenza infection during pregnancy; (2)
general practitioners’ knowledge and perceptions about
influenza vaccination during pregnancy; and (3) general
practitioners’ approach to promoting and providing in-
fluenza vaccination during pregnancy.
(1) General practitioners risk perception of influenza
infection during pregnancy
Overall the general practitioners were not concerned about
the risks associated with influenza during pregnancy. One-third did not consider influenza during pregnancy to be a
serious risk for the mother or the baby. Two-thirds
thought that there was an increased risk associated with
influenza during pregnancy, and mentioned miscarriage or
premature labor as potential consequences. Some thought
that the risks of infection were specifically associated with
the H1N1 strain of the 2009 pandemic and not other influ-
enza strains. Other general practitioners said that although
they were aware that the risks are reported to be higher in
pregnant women compared to the general population, they
had no direct experience of a pregnant patient contracting
influenza and having serious consequences, and that this
in turn decreased their perception of the risk. Many did
not perceive that pregnancy alone placed a woman in a
high-risk category for influenza, and felt that only pregnant
women with other co-morbidities, such as respiratory dis-
ease or obesity, were at risk of complications.
“I'm aware that if women get the influenza virus
during pregnancy complications are much higher,
the severity of the influenza is much higher and so
we ought to be vaccinating women during
pregnancy”.
“I guess the same (risks) as anyone who doesn’t have a
pregnancy. Whether it brings on pre-term labour,
possibly, but I am not aware of any specific problems
directly related to the pregnancy”.
“I think with the number of people (pregnant women)
who catch the flu and the number of people who don’t
have any problems with it….I see it’s a small amount
of risk involved”.
(2) General practitioners knowledge, attitudes and beliefs
about influenza vaccination during pregnancy
The majority of the general practitioners were aware of
the recommendations for influenza vaccination during
pregnancy, but most were not confident on all aspects of
the recommendations, particularly in relation to timing.
Some thought the recommendation specified provision
during a specific trimester or only during the influenza
season. Some wondered why this recommendation had
become a priority.
“So I am fully aware that it is recommended that they
get their influenza vaccine if they are going to be
pregnant in the flu season, particularly second and
third trimester”.
“The thing that surprised us is why suddenly there
is a push for vaccinating for flu in pregnant
woman….most of us are quite surprised that it is
recommended”.
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given flu needles to pregnant women we haven't run
into much significant problems”.
Most general practitioners identified that influenza
vaccination during pregnancy would be beneficial in pre-
venting consequences of infection such as miscarriage or
premature labour. Very few specifically nominated the
benefits of vaccination for the baby, and when ques-
tioned had varied opinions about this.
More than half of the general practitioners had signifi-
cant concerns about the safety of the vaccine during
pregnancy. Many of these general practitioners raised
the issue of time – providing the influenza vaccine dur-
ing pregnancy is a relatively recent practice and they felt
that there needed to be a longer period of time where
this was practiced without adverse outcomes before they
could be confident that the vaccine was completely safe
for pregnant women. A number of the general practi-
tioners were concerned that if they provided the vaccine
to pregnant women and an adverse event subsequently
occurred (which may or may not be related to the vac-
cine), that women may blame the vaccine and hold the
practitioner liable. Some were particularly concerned
that the influenza vaccine was rated in product informa-
tion as Australian Category B2 (drugs which have been
taken by only a limited number of pregnant women and
studies in animals are lacking but available data shows
no evidence of harmful effects on the foetus [35]).
“I’m not fully convinced that it’s totally safe to them, no”.
“I think it is more of an unknown and you tend to be
more conservative about what you give [pregnant]
patients”.
“With the small amount of risk involved [with
influenza] I don’t see that the benefits [of the
vaccination] outweigh the risks”.
“My understanding is it category B in pregnancy.
Which is a little bit of grey area…. If it was Category
A I would be much more likely to recommend it.”
“We have to wait and see whether the information is
correct. Most times after a few years you find out that
the information might not be that accurate.”
“I just think if they had the flu injection, then whether it
was a day, a month, or at any stage after getting the
vaccine, that if anything went wrong like foetal death or
early labour, I know that they would look at pointing
the finger at the flu vaccine as the cause. Whether it is
or not. So it is safer as a doctor not to do that”.The general practitioners who were confident that the
vaccine is safe were either more informed about the evi-
dence regarding safety of the vaccine in pregnancy, or
were more willing to trust that the vaccine is safe and
beneficial based on the fact that it is recommended
under the national immunisation guidelines. Most of this
group recommended the vaccine to pregnant women
and had not observed any adverse outcomes which rein-
forced their belief that it is safe.
“Yes, well, it was recommended from the health
department to do so I would assume that the
information is accurate and there's no risk in doing it
so I'm happy to follow that”.
“I’ve given it during pregnancy for a few patients and I
haven’t noticed anything unusual”.
Few general practitioners were confident about their
knowledge regarding influenza vaccination during preg-
nancy. Most felt that they needed more information;
however none reported actively searching to obtain in-
formation. Many reported challenges in information
management and staying aware of recent research and
evidence. Many interviewees specifically asked questions
of the interviewer to obtain information about the guide-
lines and evidence.
“I would take it that somewhere in the world they’ve
been vaccinating pregnant women for a reasonably
length period and I would probably like to look at
some figures in relation to that as to the number of
adverse effects that occur and the efficacy of doing it”.
(3) General practitioners approach to promoting and
providing influenza vaccination during pregnancy
The general practitioners’ approach to recommending
and providing the influenza vaccine during pregnancy
was related to their perception of the risks associated
with influenza infection during pregnancy, their confi-
dence in the safety of the vaccine during pregnancy, and
also more practical issues such as limited consultation
time to cover issues like vaccination with their patients.
Of the two-thirds of those who reported that they rec-
ommend the vaccine to their pregnant patients, either
intermittently or routinely, the majority recommend the
vaccine during the autumn/early winter period, or in a
specific trimester (either first or third). Some general
practitioners only recommended it to pregnant patients
who have higher risks associated with infections due to
other conditions such as asthma or chronic disease. A
number of general practitioners who were not confident
in the safety of the vaccine reported recommending it to
patients purely because of the guidelines. The general
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from larger practices, were not registered antenatal
shared care providers, and included both male and fe-
male general practitioners. Some general practitioners
reported challenges in prioritising competing demands
during a consultation with a pregnant woman, and that
influenza vaccination was often not a high priority, or
something that they did not always remember to do.
“If the patient comes to me, and they’re in the first
trimester, and it’s winter, I would give it to them”.
“I don’t like the concept of giving a flu vaccine during
the first trimester, I would rather wait till later on and
that’s what I’ll do.”
“If they are otherwise fit healthy people with no
asthma or other particular indications to have the flu
injection, I wouldn’t – I probably wouldn’t advise
having it”.
“It’s not high on my priority. I think around March,
when the flu vaccines come out, you tend to be much
more likely to bring it up with patients, or they will
bring it up with you.”
All general practitioners said that the majority of their
pregnant patients were not aware that the influenza vac-
cine was recommended, and that most were initially re-
luctant to receive the vaccine due to safety concerns.
They reported that only on rare occasions would a preg-
nant patient request the vaccine because they had heard
about it elsewhere. The general practitioners who rec-
ommended the vaccine described their approach to the
topic of influenza vaccination with their patients as in-
volving an explanation of the risks of infection, benefits
of vaccination, and reassurance that the vaccine is safe.
“They’re [pregnant women] always worried about side
effects from it in terms of relating to the pregnancy but
with a bit of explanation their fears can be allayed
usually”.
“I think it’s more educating the patient because they’re
not comfortable to have injection or anything during
pregnancy but we have to offer it. I think I just have to
convince them that given the pros and cons during
pregnancy I think I have no problem. Initially I have
some difficulty of convincing the pregnant lady to have
the injection”.
Many of the general practitioners who recommend the
vaccine reported that while they would advise the patient
to be vaccinated according to the guidelines, they wouldultimately leave the decision regarding vaccination to
their patient. They saw influenza vaccination during
pregnancy as a personal choice, and were not willing to
strongly recommend it. These were predominantly the
general practitioners who were not confident about the
safety of the vaccine, and those who feared adverse out-
comes or being blamed if there was an adverse outcome.
One stated that they felt they could not be held liable
for not recommending the vaccination.
“We do not push it. We do not insist. We just advise
them. If they accept that's fine”.
“It’s a personal choice thing, so I don’t impose too
much education on them at that stage because I’m not
sure myself. I’m not fully convinced that it’s totally safe
to them, no.”
“I'd even probably be relieved if they gave an
indication that they weren't keen or felt a little bit
uneasy, I would probably encourage that because then
that's easier. (Then) there's no risk of anything going
wrong with the vaccination. Kind of a ‘first do no
harm’ kind of thing”.
The general practitioners who do recommend the vac-
cine to pregnant women reported varied rates of accept-
ance and uptake among their pregnant patients. Most
general practitioners reported that “most” or “some” of
their patients would agree to receive the vaccine once
recommended, while a few reported that they had not
yet convinced one pregnant patient to accept it. The
general practitioners with more success identified a
strong patient-doctor relationship and their patients hav-
ing trust in them as important factors in patients accept-
ing the vaccine, and some identified that as a general
practitioner, they have significant power in convincing
patients to accept the vaccine.
“I have a good relationship with the patients and
if I recommend it they probably would take it on
board”.
“I've got very convincing powers. They trust. I guess
having a family doctor, they do trust.”
“They will take it positively if I am positive about it. If
I say it is good they will see it as good. This is for the
most part anyway”.
“It depends on how long you have the relationship as a
doctor because I’m just new here so sometimes there’s
some difficulty of getting them to trust me because they
don’t know me”.
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Many of the general practitioners interviewed in this
study demonstrated limited knowledge about the risks of
influenza infection and vaccination during pregnancy, or
expressed limited confidence in the safety of the vaccine.
These general practitioners may therefore either not be
recommending the vaccine, or recommending it with
varying levels of clarity and conviction. This may impact
upon the fact that only a few general practitioners were
able to report high acceptance of the vaccine among
their pregnant patients. Our research findings concur
with the results of previous studies which report that
other antenatal care providers have varying levels of
knowledge about influenza vaccination during pregnancy
[22,28-30,36]. This is significant, as increased levels of
provider knowledge are associated with higher rates of
influenza vaccination in pregnant patients [28].
This is the first study to ascertain the attitudes, per-
ceptions, and practices of Australian general practi-
tioners towards influenza vaccination during pregnancy,
and the qualitative methods used enabled us to capture
rich information about their perspectives which could
not have been garnered from a written survey. Semi-
structured interviews were identified as the most appro-
priate data collection method to minimise participant
burden and maximise the participation rate, as the inter-
view could be conducted in the general practitioner’s
workplace. It was anticipated that the participation rate
for focus group discussions would be low. The limitation
of this study is that only 17 of the 44 general practi-
tioners invited to participate in the study agreed to par-
ticipate. A greater number of interviews may have
provided greater diversity of practice types. The re-
sponses of the general practitioners may have been af-
fected by the fact that the interviewer is a NSW public
health employee, however the findings did not indicate
that they were reluctant to report practices and attitudes
that were contrary to current guidelines.
In our study, general practitioners appear to base their
overall risk assessment on their perceptions of the risk
of influenza infection during pregnancy, the benefits and
risks of the influenza vaccine, as well as their personal
experiences of influenza. General practitioners appear to
perceive the risks associated with maternal influenza in-
fection to be lower than the evidence suggests, while
conversely, their perception of the risks associated with
the vaccine seem to be higher. Based on their risk assess-
ments, general practitioners appear to be demonstrating
two decision-making biases which influence whether and
how they recommend the vaccine. Firstly, omission bias
(choosing to do nothing with some probability of harm
over doing something with a lower probability of equiva-
lent harm) is demonstrated with general practitioners
choosing to not recommend influenza vaccination, eventhough the probability of harm from influenza during
pregnancy is higher than the probability of harm from the
vaccine [15,37]. Omission bias is greater when practi-
tioners anticipate that they will feel regret should an
adverse outcome occur. However practitioners may antici-
pate a greater sense of regret if they perceive that the out-
come could be the result of their own action rather than
lack of action [38,39]. The general practitioners inter-
viewed in our study clearly indicated anticipating regret
(and fearing liability) should an adverse outcome occur
due to the vaccine. Omission bias has been observed in
parents deciding whether or not to vaccinate their child
against pertussis, [40] and in practitioners deciding
whether or not to recommend hormone replacement
therapy for women [41]. Secondly, ambiguity bias (avoid-
ing an option when information about the consequences
is perceived to be missing [36]) is also observed here, with
some general practitioners perceiving that more time is
required to demonstrate that the use of the vaccine during
pregnancy is safe. Both these decision-making biases may
be limiting the extent to which the general practitioners
provide influenza vaccination during pregnancy, and strat-
egies aimed at improving the frequency of influenza vac-
cination to pregnant women by general practitioners
should address these biases.
While the majority of the general practitioners re-
ported intermittently recommending the vaccine, they
reported varied levels of acceptance of the vaccine by
their pregnant patients, which may be related to the
quality, style, and consistency of the recommendation
they give. This may in turn be related to our finding that
these practitioners often lack confidence in their know-
ledge of the evidence, or in the safety of the vaccine for
pregnant women. Many of the general practitioners re-
ported that they are adopting the principles of patient
informed choice – they are reluctant to provide a strong
opinion or recommendation to their patients, often due
to their own lack of confidence in the safety of the vac-
cine and their fear the consequences of liability should
something go wrong. Those interviewed stated that they
believe it is the patient’s decision whether they receive
the vaccine or not, and pregnant women are therefore
expected to decide for themselves. However, an in-
formed decision requires relevant good quality informa-
tion, [42] and it appears that pregnant women may not
receive clear information from their general practitioner
on the risks of influenza, and the benefits and risks of
the vaccine. A qualitative survey of post-partum women
in Switzerland indicated that they perceived that the in-
formation they received about vaccination from a pro-
vider, when given, lacked unequivocal advice and a sure
recommendation [43]. Significant challenges have been
reported regarding patient informed decision making -
even when good information is provided patients face
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or when they are required to weigh benefits and risks
[44]. In relation to influenza vaccination during preg-
nancy, women have indicated that they feel it is the
physician who should explain the choice of whether to
be vaccinated or not, and if the message was clear and
unequivocal then they would follow the recommenda-
tion [42]. Even women who have safety concerns about
the vaccine still indicate that they would accept it if the
provider recommended it [23].
These interviews were undertaken approximately six
months after the implementation of a number of strat-
egies aimed to increase awareness of maternal influenza
vaccination during pregnancy among general practi-
tioners, including a letter and a brochure, however only
a small number of interviewees recalled the information
contained in these documents. A survey of post-partum
women in the same region conducted concurrently with
this study found the rate of vaccine uptake among preg-
nant women to be 25% during the 2012 influenza sea-
son, and that only 30% of women could recall receiving
a recommendation for the vaccine from an antenatal
health care provider during their pregnancy [45]. This
suggests that the strategies undertaken were not suffi-
cient to increase rates of provider recommendation and
vaccine uptake to acceptable levels. Different strategies
may be required that more clearly address the risk per-
ceptions of general practitioners identified in this study,
and as many interviewees raised the issue of requiring
more time to increase their confidence, it may be ex-
pected that changes in practice regarding this issue may
not occur quickly.
We have not located any research that has investigated
how to improve rates of vaccination recommendation in
general practitioners across a region; however a number
of studies conducted at single antenatal clinic sites have
demonstrated that it is possible to increase provider
knowledge about influenza vaccination during preg-
nancy, rates of provider recommendation or patient ac-
ceptance of the vaccine through strategies targeting
providers, pregnant women, or both. Strategies targeting
women include displaying posters in the clinics and pro-
viding patients with information brochures, and strat-
egies targeting providers include provider education
programs, reminder stamps in patient’s files, e-mail re-
minder to providers, and making the vaccine available in
the clinic [21,46,47]. In an obstetric hospital in Melbourne
the implementation of a combination of these strategies
saw influenza vaccination coverage increase from 30 to
40%, and rates of provider recommendation increasing
from 37% to 62.5% [21]. The inclusion of an electronic
best practice alert about influenza vaccination in each pa-
tient’s electronic medical record in an antenatal clinic in
Wisconsin saw vaccination coverage improve from 42% to61% and provider recommendation rates improve from 49
to 89% [48]. This strategy could translate well to the gen-
eral practice context in Australia, where electronic deci-
sion support for cardiovascular disease management in
general practice shows promising potential to increase
provider adherence to best practice guidelines [49]. A
number of general practitioners in this study reported
that influenza vaccination during pregnancy is not al-
ways their key priority and they often forget to mention
it, and some suggested an electronic reminder could as-
sist with this. Others also recommended that if women
were more aware and knowledgeable about the vaccin-
ation it would make their job easier to convince them,
and suggested that a public awareness campaign could
assist with this.Conclusion
General practitioners have varied knowledge, attitudes
and beliefs about influenza vaccination during pregnancy
and this is likely to influence both the number of recom-
mendations given to pregnant women, and the convic-
tion with which these recommendations are made. This
study indicated that general practitioners have a low per-
ception of risk of influenza during pregnancy, and have
considerable concerns about vaccine safety and potential
liability, and additional research could further investigate
these issues. Providing clear information and communica-
tion to general practitioners on the current recommenda-
tions regarding influenza vaccination during pregnancy,
and the evidence upon which they are made, may increase
provider knowledge and confidence in recommending the
vaccine, which is likely to improve influenza vaccine cover-
age among Australian pregnant women.Competing interests
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